Shuidi Huzhu closes USD200m Series D, valued at USD2b

Shuidi Huzhu has closed a new round of funding of nearly 200 million US dollars last month, which valued the company at about two billion US dollars.

Shuidi Huzhu has closed a new round of funding of nearly 200 million US dollars last month, which valued the company at about two billion US dollars.

However, people with knowledge of the matter did not disclose the specific investors, only that the lead investor was an international giant insurance company.

In late July, it was reported that Shuidi was preparing for an IPO and was currently in contact with Goldman Sachs and Bank of America to select underwriters.

As for the choice of listing location, the company prefers the U.S. market. The source revealed that the current expected date is the end of 2020, or early 2021, while the latest IPO valuation of the company is four to six billion US dollars.

Founded in 2016, Shuidi is a provider of a healthcare crowdfunding platform designed to reduce the financial burden of those inflicted with injury or disease.

The company’s medical expense crowdfunding platform helps to raise capital from other users’ membership fee for patients who are unable to pay medical bills resulting from unexpected illnesses and accidents, enabling people to gain financial assistance to cover healthcare bills.

Shuidi has previously completed at least four rounds of funding from investors including Tencent, Meituan Dianping, IDG, BlueRun Ventures and Gaorong Capital.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/08/14/shuidi-huzhu-closes-usd200m-series-d-valued-at-usd2b/.

Leave a Reply

Please Login to Comment